Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 12
Submit an article Journal homepage
155
Views
2
CrossRef citations to date
0
Altmetric
Letter

Absence of miR-142 mutation in Chinese patients with acute myeloid leukemia

Fei-Fei ChenInstitute of Hematology, Zhejiang University, Hangzhou, China
,
Yin-Jun LouDepartment of Hematology, the First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
,
Jian ChenInstitute of Hematology, Zhejiang University, Hangzhou, China
,
Jing JinInstitute of Hematology, Zhejiang University, Hangzhou, China
,
Jia-Ni ZhouInstitute of Hematology, Zhejiang University, Hangzhou, China;Department of Hematology, the Affiliated Lihuili Hospital of Medical College, Ningbo University, Ningbo, China
,
Xiu-Feng YinInstitute of Hematology, Zhejiang University, Hangzhou, China
,
Zhi-Juan ZhuInstitute of Hematology, Zhejiang University, Hangzhou, China
,
Chao HuInstitute of Hematology, Zhejiang University, Hangzhou, China
,
Meng-Xia YuInstitute of Hematology, Zhejiang University, Hangzhou, China
,
Huan-Ping WangInstitute of Hematology, Zhejiang University, Hangzhou, China
&
Jie JinInstitute of Hematology, Zhejiang University, Hangzhou, China;Department of Hematology, the First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, ChinaCorrespondence[email protected]
 show all
Pages 2961-2962 | Received 26 Sep 2013, Accepted 18 Mar 2014, Published online: 07 May 2014

References

  • Ley TJ, Miller C, Ding L, et al.; Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013;368:2059–2074.
  • Chen CZ, Li L, Lodish HF, et al. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004;303:83–86.
  • Bissels U, Wild S, Tomiuk S, et al. Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133 + and CD34 + hematopoietic stem and progenitor cells. Stem Cells 2011;29:847–857.
  • Huang B, Zhao J, Lei Z, et al. miR-142-3p restricts cAMP production in CD4 + CD25- T cells and CD4 + CD25+ TREG cells by targeting AC9 mRNA. EMBO Rep 2009;10:180–185.
  • Sun Y, Varambally S, Maher CA, et al. Targeting of microRNA-142-3p in dendritic cells regulates endotoxin-induced mortality. Blood 2011;117:6172–6183.
  • Wu L, Cai C, Wang X, et al. MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells. FEBS Lett 2011;585:1322–1330.
  • Kee HJ, Park S, Kwon JS, et al. B cell translocation gene, a direct target of miR-142-5p, inhibits vascular smooth muscle cell proliferation by down-regulating cell cycle progression. FEBS Lett 2013; 587:2385–2392.
  • Kwanhian W, Lenze D, Alles J, et al. MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma. Cancer Med 2012;1:141–155.
  • Saito Y, Suzuki H, Tsugawa H, et al. Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication. PloS One 2012;7:e47396.
  • Lv M, Zhang X, Jia H, et al. An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-alpha and cAMP/PKA pathways. Leukemia 2012;26:769–777.
  • Wang F, Wang XS, Yang GH, et al. miR-29a and miR-142-3p downregulation and diagnostic implication in human acute myeloid leukemia. Mol Biol Rep 2012;39:2713–2722.
  • Dahlhaus M, Roolf C, Ruck S, et al. Expression and prognostic significance of hsa-miR-142-3p in acute leukemias. Neoplasma 2013; 60:432–438.
  • Jin J, Wang JX, Chen FF, et al. Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial. Lancet Oncol 2013;14:599–608.
  • Shen Y, Zhu YM, Fan X, et al. Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia. Blood 2011;118:5593–5603.
  • Wang L, Xu WL, Meng HT, et al. FLT3 and NPM1 mutations in Chinese patients with acute myeloid leukemia and normal cytogenetics. J Zhejiang Univ Sci B 2010;11:762–770.
  • Kottaridis PD, Gale RE, Frew ME, et al. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood 2001;98:1752–1759.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.